Infantile Hemangiomas: Complications and follow-up

[1]  S. LeVine,et al.  Hemangioma Update: Pearls From 30 Years of Treatment , 2012, Annals of plastic surgery.

[2]  F. Blei.  Oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol. , 2012, Plastic and reconstructive surgery.

[3]  P. Leadbitter,et al.  Pharmacologic Therapies for Infantile Hemangioma: Is There a Rational Basis? , 2011, Plastic and reconstructive surgery.

[4]  S. Friedlander,et al.  Twenty years' experience of steroids in infantile hemangioma—a developing country's perspective , 2010 .

[5]  I. Frieden,et al.  Comparison of infantile hemangiomas in preterm and term infants: a prospective study. , 2008, Archives of dermatology.

[6]  Anne W. Lucky,et al.  Growth Characteristics of Infantile Hemangiomas: Implications for Management , 2008, Pediatrics.

[7]  M. T. Dueñas-González,et al.  Treatment with Interferon‐α‐2b in Children with Life‐Threatening Hemangiomas , 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[8]  S. Raimer.  Multicenter Prospective Study of Ulcerated Hemangiomas , 2008 .

[9]  I. Frieden,et al.  Prospective Study of Infantile Hemangiomas: Clinical Characteristics Predicting Complications and Treatment , 2006, Pediatrics.

[10]  M. Garzón,et al.  How to Measure a Growing Hemangioma and Assess Response to Therapy , 2006, Pediatric dermatology.

[11]  D. Siegel,et al.  Infantile Hemangiomas: Current Knowledge, Future Directions. Proceedings of a Research Workshop on Infantile Hemangiomas , 2005, Pediatric dermatology.

[12]  B. Drolet,et al.  Treatment of hemangiomas of infancy , 2005, Dermatologic therapy.

[13]  V. Sharma,et al.  Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. , 2004, Archives of dermatology.

[14]  J. Mulliken,et al.  Congenital hemangiomas and infantile hemangioma: missing links. , 2004, Journal of the American Academy of Dermatology.

[15]  A. Picard,et al.  Traitement par vincristine des hémangiomes graves du nourrisson , 2004 .

[16]  A. Picard,et al.  [Vincristine treatment for function- and life-threatening infantile hemangioma]. , 2004, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[17]  I. Frieden,et al.  Hemangiomas of infancy. , 2003, Journal of the American Academy of Dermatology.

[18]  J. Werner,et al.  Optimal Treatment of Vascular Birthmarks , 2003, American journal of clinical dermatology.

[19]  M. Colombo,et al.  Ulcerated hemangiomas: clinical characteristics and response to therapy. , 2001, Journal of the American Academy of Dermatology.

[20]  L. Carmant,et al.  Toxicity profile of interferon alfa-2b in children: A prospective evaluation. , 1999, The Journal of pediatrics.

[21]  J. Mulliken,et al.  Complications of systemic corticosteroid therapy for problematic hemangioma. , 1999, Plastic and reconstructive surgery.

[22]  R. Smith,et al.  An update on the treatment of hemangiomas in children with interferon alfa-2a. , 1999, Archives of otolaryngology--head & neck surgery.

[23]  I. Frieden.  Which hemangiomas to treat--and how? , 1997, Archives of dermatology.